Results 21 to 30 of about 340,819 (312)

GSK3-beta as a candidate therapeutic target in soft tissue sarcomas

open access: yesJournal of Hematology & Oncology, 2021
Soft tissue sarcoma (STS) is a predominantly fatal rare malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies. Its therapeutic relevance in STS is unknown.
S. Verbeke   +7 more
doaj   +1 more source

Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study [PDF]

open access: yes, 2020
Background We recently reported outcomes from a Scandinavian Sarcoma Group adjuvant study (SSG XX group A) conducted on localized and operable high risk soft tissue sarcoma (STS) of the extremities and trunk wall.
Bruland, Øyvind S.,   +36 more
core   +1 more source

Myoepithelial carcinoma with RB1 mutation: remarkable chemosensitivity to carcinoma of unknown origin therapy

open access: yesBMC Cancer, 2017
Background Myoepithelial carcinoma of soft tissue is a rare, malignant neoplasm that is morphologically and immunophenotypically similar to its counterpart in salivary gland.
Timothy M. Hoggard   +9 more
doaj   +1 more source

Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors [PDF]

open access: yes, 2020
Background To report on our experience using a simple optional form to facilitate communication on late effects between the patients and the oncologists during outpatient follow-up and to detail on the spectrum of challenges reported by sarcoma survivors.
Hompland, Ivar   +4 more
core   +1 more source

Optimization of the therapeutic approach to patients with sarcoma: Delphi Consensus [PDF]

open access: yes, 2019
Delphi consensus; Sarcoma treatment; Panel of expertsConsenso Delphi; Tratamiento del sarcoma; Panel de expertosConsens Delphi; Tractament del sarcoma; Panell d'expertsSoft tissue sarcomas (STS) constitute a heterogeneous group of rare solid tumors ...
Martin-Broto, Javier   +10 more
core   +1 more source

Foreign Body Granulomas Induced by Intramuscular Leuprorelin Acetate Injection for Prostate Cancer: Clinical Mimics of Soft Tissue Sarcoma

open access: yesCase Reports in Oncological Medicine, 2015
We describe two cases of florid, foreign body granulomatous reaction occurring in the upper arms of males in their eighth decade, who were undergoing treatment with depot injection of leuprorelin acetate for prostatic carcinoma.
Khin Thway   +3 more
doaj   +1 more source

Primary Renal Synovial Sarcoma

open access: yes, 2022
Primary renal synovial sarcoma is a rare malignancy that may present similarly to other renal neoplasms. The diagnosis of synovial sarcoma is performed through the identification of a SYT-SSX gene fusion.
Ricardo A. Rendon   +6 more
core   +1 more source

Metastatic Ewing's sarcoma to the right ventricle [PDF]

open access: yes, 2011
Ewing's sarcoma is a round cell neoplasm derived from neural crest cells that is part of the primitive neuroectodermal tumor (PNET) family. It is a rare, aggressive malignancy that affects young people, most commonly in the second decade of life.
Milliken, Jeffrey   +5 more
core  

A critical review of the impact of sarcoma on psychosocial wellbeing [PDF]

open access: yes, 2019
Background. Previous reviews of outcomes in specific sarcoma populations suggest patients have poor quality of life. In most of these reviews, there is a predominant focus on physical function rather than psychosocial outcome.
Whelan, JS   +10 more
core   +1 more source

Ovarian Sex Cord Stromal Tumors in Children and Adolescents—The European Standard Clinical Practice Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT As part of the European Cooperative Study Group for Paediatric Rare Tumours initiative, we developed standard clinical practice guidelines for ovarian sex cord stromal tumors, based on comprehensive national and international cohort analyses, literature review, and a final expert consensus conference.
Dominik T. Schneider   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy